Lu Wen
Impact in
-
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Heme Oxygenase-1 and Carbon Monoxide 4
- Plant Reproductive Biology 3
-
- Natural Compound Pharmacology Studies 4
- Co-authors
- Jianli Hu (3 shared papers)Shengli Yang (2 shared papers)Yan Chen (3 shared papers)Fei Zhao (4 shared papers)Rui Li (3 shared papers)Yuan Liu (3 shared papers)Yuan Liu (1 shared paper)Fei Zhao (2 shared papers)
- Journals
- Oncology Reports (2 papers)Acta Pharmacologica Sinica (2 papers)Scientific Reports (2 papers)Medicinal Chemistry Research (1 paper)PLoS ONE (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Lu Wen
49 papers receiving 533 citations
Peers
Comparison fields: 5 of 81
- Cancer Research 80
- Complementary and alternative medicine 32
- Oncology 91
- Molecular Biology 246
- Immunology 61
Countries citing papers authored by Lu Wen
This map shows the geographic impact of Lu Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Wen more than expected).
Fields of papers citing papers by Lu Wen
This network shows the impact of papers produced by Lu Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Wen. The network helps show where Lu Wen may publish in the future.
Co-authors
The 25 scholars most cited alongside Lu Wen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 60 | |
| 2 | 2009 | 52 | |
| 3 | 2016 | 36 | |
| 4 | 2011 | 35 | |
| 5 | 2022 | 32 | |
| 6 | 2019 | 30 | |
| 7 | 2012 | 27 | |
| 8 | 2015 | 22 | |
| 9 | 2014 | 19 | |
| 10 | 2015 | 17 | |
| 11 | 2010 | 14 | |
| 12 | 2017 | 13 | |
| 13 | 2024 | 12 | |
| 14 | 2021 | 12 | |
| 15 | 2020 | 11 | |
| 16 | 2020 | 10 | |
| 17 | 2016 | 10 | |
| 18 | 2017 | 10 | |
| 19 | 2025 | 9 | |
| 20 | 2022 | 9 |
About Lu Wen
Lu Wen is a scholar working on Molecular Biology, Plant Science, Oncology, Pulmonary and Respiratory Medicine and Cell Biology, having authored 52 papers that have together received 535 indexed citations. Recurring topics across this work include Heme Oxygenase-1 and Carbon Monoxide (4 papers), Natural Compound Pharmacology Studies (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), Synthesis of Organic Compounds (3 papers), Natural Compounds in Disease Treatment (3 papers), Plant Reproductive Biology (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Plant Pathogens and Fungal Diseases (2 papers). The work is most often cited by research in Cancer Research (80 citations), Complementary and alternative medicine (32 citations), Oncology (91 citations), Molecular Biology (246 citations) and Immunology (61 citations). Lu Wen has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Jianli Hu, Shengli Yang, Yan Chen, Fei Zhao, Rui Li, Yuan Liu, Yuan Liu, Fei Zhao, Sha Yi and Chun Zhang. Their work appears in journals such as Oncology Reports, Acta Pharmacologica Sinica, Scientific Reports, Medicinal Chemistry Research and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.